section name header

Y-Site Injection Compatibility (1:1 Mixture)

Cefiderocol sulfate tosylate

(Mfr: SHI)(Conc: 20 mg/mLb)

I

Vancomycin HCl

(Mfr: GLA)(Conc: 5 mg/mLb)

Remarks:

Results of subvisual tests indicate the presence of cloudiness with white particles

Ref:

3662